PATENT CLAIM ANALYSIS

Application Number: 16108064
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "006500"]

Abstract:
The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.

Claim (Index 12):
The aqueous pharmaceutical formulation of  claim 11  further comprising 90 \u03bcg/mL zinc, 2.7 mg/mL m-cresol, and 20 mg/mL glycerol 85%.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 96.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14220562', '14781857', '12778719', '15616470', '13826806']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7131420467616082
- 35 USC 102 Novelty (BERT): 0.6693532492446557
- Combined Prediction Score: 0.7087631670099129
- Mean Citation Score: 380.42463400000014
- Max Citation Score: 644.0298
- Similarity Product: 637.4288578461527

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test